Lineage Cell Therapeutics Logo

Lineage Cell Therapeutics

🇺🇸
LCTX
US53566P1093

Lineage Cell Therapeutics is a US-based biopharmaceutical company dedicated to the development and commercialization of allogeneic cell therapies. The company leverages pluripotent stem cells to research and clinically develop innovative regenerative medicine solutions for serious diseases, focusing on creating novel treatment options.

Next Quarterly Earnings

Thursday, August 6, 2026
CW 32
After-Hours
In 32 days

Stock Price

All Dates

Company Information

Name
Lineage Cell Therapeutics
Ticker Symbol
LCTX
ISIN
US53566P1093
Country
🇺🇸
USA